Stockreport
BioFuture™ 2024 Wraps Up: Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Media [Yahoo! Finance]
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
NEW YORK, November 22, 2024 BUSINESS WIRE )--Demy-Colton's BioFuture™ conference wrapped up in New York and virtually with the largest turnout in the event's history. 100+ speakers, 100+ investors, 62 presenting companies and 48 journalists participated in dozens of public, private and seed-stage innovation company presentations, 2,085 one-to-one meeting requests, 440 meetings scheduled and media interviews focused on the future of the life sciences, diagnostics, techbio, pharmaceutical, health delivery and digital health sectors. BioFuture's "Big Think" Plenary Sessions, fireside chats and workshops are poised to transform healthcare over the coming decade – from policy to AI and bioelectronics to the evolving funding landscape, among others. Speakers included: Susan Hockfield, Ph.D., former president of MIT Kevin Tracey, M.D., President and CEO, Feinstein Institutes for Medical Research at Northwell Health Wade Davis, Vice President of Computational Science & Head of Digi
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | REGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
REGN alerts
REGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
NEWS
NEWS
- Vyriad signs 'huge' deal with Novartis to develop new cancer treatments [Yahoo! Finance][Yahoo! Finance]
- Here's Why Regeneron Pharmaceuticals (REGN) Declined in Q3 [Yahoo! Finance][Yahoo! Finance]
- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.[MarketBeat]
- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $1,150.00 price target on the stock.[MarketBeat]
- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Citigroup Inc. to a "hold" rating.[MarketBeat]
- More
REGN
SEC Filings
SEC Filings
- 11/12/24 - Form 4
- 11/5/24 - Form 4
- 11/1/24 - Form 144
- REGN's page on the SEC website
- More